Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
04/2003
04/09/2003EP1299354A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
04/09/2003EP1299352A2 Compounds to treat alzheimer's disease
04/09/2003EP1299349A2 Compounds to treat alzheimer's disease
04/09/2003EP1140055B1 Use of a 5ht 2a? and 5ht 2a/c? receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways
04/09/2003EP1133473B1 New manufacturing process
04/09/2003EP1082116B1 Use of 4-piperidinemethanol derivatives in treatment of neurodevelopmental disorders
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0993458B1 3-benzylpiperidine
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
04/09/2003EP0674623B1 Bicyclic fibrinogen antagonists
04/09/2003CN1409703A 4-aminopiperidine derivatives and their use as medicine
04/09/2003CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds
04/09/2003CN1105104C New manufacturing process
04/09/2003CN1105102C Amino-butenate compound and preparation method thereof
04/09/2003CN1104892C Method for curing tinnitus by nerve protecting agent
04/08/2003US6545156 Automobile overcoatings
04/08/2003US6545071 Stabilizer mixtures
04/08/2003US6545037 Thromboxane A2 (TXA2) receptor and 5HT2 serotonergic receptor antagonists; 3-(6-(((4-chlorophenyl)sulphonyl)amino)-3-((2-(4-methyl-1 -piperazinyl)phenoxy)methyl)-5,6, 7,8-tetrahydro-1-naphthyl)propanoic acid for example
04/08/2003US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane
04/08/2003US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders
04/08/2003US6545021 Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
04/08/2003US6545018 Oxamic acids and derivatives as thyroid receptor ligands
04/08/2003US6544992 Carbonylamino pyrrolidine and piperidine derivatives
04/08/2003US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation
04/08/2003US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation
04/08/2003CA2123548C Piperazine derivatives
04/07/2003WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
04/04/2003WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/04/2003CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same
04/03/2003WO2003027068A2 Substituted amines for the treatment of neurological disorders
04/03/2003WO2003011295B1 Fexofenadine polymorph
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065186 Antihistamines, antiallergens, bronchodilator
04/03/2003US20030065184 Stabilizer for addition polymer
04/03/2003US20030065013 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
04/03/2003US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
04/03/2003US20030064987 Immunology moderators; interleukin antagonist; anticancer agents
04/03/2003US20030064980 Respiratory system disorders; antiinflammatory agents
04/03/2003US20030064976 Reacting ammonium formate, aldehyde and alkyl isocyanate
04/03/2003US20030064954 Gene therapy; vaccines; calcium channel blockers; cardiovascular disorders
04/03/2003CA2461603A1 Substituted amines for the treatment of neurological disorders
04/02/2003EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296950A2 Aminopiperidines for use as glyt-1 inhibitors
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296687A2 Treatment of male sexual dysfunction
04/02/2003EP1296684A2 Treatment of gastroesophageal reflux disease using piperidine derivatives
04/02/2003EP0956286B1 Synthesis of terfenadine and derivatives
04/02/2003EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders
04/02/2003CN1407970A Urea compounds having muscarinic receptor antagonist activity
04/02/2003CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
04/02/2003CN1104416C Racemisation and asymmetric transformation process used in manufacture of levobupivacaine and analogues thereof
04/02/2003CN1104410C Phenyl acetic acid derivatives, process and intermediate products for their production and agents containing them
04/02/2003CN1104241C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetraphdropyridine for preparing drugs for treating amyotrophic lateral scherosis
04/01/2003US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis
04/01/2003US6541640 Process for the preparation of 4-haloalkylnicotinonitriles
04/01/2003US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1
04/01/2003US6541477 Inhibitors of p38-a kinase
04/01/2003US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist
03/2003
03/27/2003WO2003024946A2 Oxamate derivatives containing a variously substituted nitrogen heterocycle
03/27/2003WO2003024930A1 Process for producing pipecolamide derivative
03/27/2003WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor
03/27/2003WO2003024928A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
03/27/2003WO2003024591A1 Modified alumina catalyst
03/27/2003WO2003024448A2 Inhibitors of histone deacetylase
03/27/2003WO2002060859A3 Cyclic derivatives as modulators of chemokine receptor activity
03/27/2003WO2002048111A3 Method for producing 4-haloalkyl nicotine nitriles
03/27/2003US20030060485 (+)-norcisapride
03/27/2003US20030060472 Inhibitor of the enzyme catechol-O-methyl transferase (COMT)
03/27/2003CA2465978A1 Inhibitors of histone deacetylase
03/27/2003CA2459546A1 Modified alumina catalyst
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295873A1 Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
03/26/2003EP1295867A1 Biphenyl compound
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294695A2 Substituted diamide derivatives useful as motilin antagonists
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294690A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
03/26/2003EP1294685A1 Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/26/2003EP1294657A2 Catalysis using phosphine oxide and sulfoxide compounds
03/26/2003EP1294362A1 Novel process for preparing crystalline particles
03/26/2003EP1025085B1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
03/26/2003EP0801640B1 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
03/25/2003US6538141 Method for preparing nitroxides
03/25/2003US6538138 Process and a novel intermediate for the preparation of Flecainide
03/25/2003US6538137 Cyanobiphenyl derivatives
03/25/2003US6538136 Preparation of substituted piperidin-4-ones
03/25/2003US6538012 Calcium channel blocker and can be used to treat or prevent angina or hypertension.
03/25/2003US6538007 Hydrates and method of antogonizing glycoprotein IIb/IIIa activity using these compounds is also disclosed. antagonist, inhibitor of blood platelets aggregation and inhibitor of the binding of fibrinogen to blood platelets.
03/25/2003US6538002 In particular, these compounds are useful as modulators of the chemokine receptors CCR-5 and/or CCR-3. as antiinflammatory agents
03/20/2003WO2003022835A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
03/20/2003WO2003022818A1 Method for producing 4-haloalkylnicotinic acid esters
03/20/2003WO2003022801A1 Reverse hydroxamic acid derivatives
03/20/2003WO2003022277A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
03/20/2003WO2003022246A1 Treating effects of excessive reactive oxygen species
03/20/2003WO2003022218A2 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
03/20/2003WO2003022217A2 Treatment of excessive radiation (e.g. sunburn) exposure
03/20/2003US20030055256 Alkoxy impurity is reacted with an ether cleaving agent to generate the corresponding phenol, which is separated, yielding the desired product substantially free of alkoxy impurities
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 380